Gautier J, Jus A, Villeneuve A, Jus K, Pires P, Villeneuve R
Biol Psychiatry. 1977 Jun;12(3):389-99.
The interaction between various neuroleptics and antiparkinsonian drugs was analyzed by measuring the neuroleptic plasma level before and after withdrawal of antiparkinsonian drugs. The population completing the study consisted of 32 chronic schizophrenics treated with chlorpromazine (8), levomepromazine (14), thioridazine (6), or haloperidol (4). Twenty-five were also receiving benztropine; 4, trihexyphenidyl; and 3, procyclidine. During the first 4 weeks patients remained on neuroleptics and antiparkinsonians, the latter being withdrawn during the 5th week, and the neuroleptics alone being administered during 16 following weeks. The plasma level of neuroleptics was assayed by gas liquid chromatography, once weekly in the morning at two different times. The analysis of variance showed a significant difference in neuroleptic plasma level when patients took neuroleptics only versus the period they had received neuroleptics and antiparkinsonians. The multiple comparison based on Studentized range Q0-05 revealed a significant progressive increase of neuroleptic plasma level during 12 weeks after withdrawal of antiparkinsonian drugs after which a plateau was reached. The hypothetical mechanisms of action of antiparkinsonians on neuroleptic plasma level are discussed.
通过测量停用抗帕金森病药物前后的抗精神病药物血浆水平,分析了各种抗精神病药物与抗帕金森病药物之间的相互作用。完成该研究的人群包括32名接受氯丙嗪(8例)、左美丙嗪(14例)、硫利达嗪(6例)或氟哌啶醇(4例)治疗的慢性精神分裂症患者。其中25人还同时服用苯海索;4人服用苯海索;3人服用丙环定。在最初的4周内,患者继续服用抗精神病药物和抗帕金森病药物,后者在第5周停用,随后在接下来的16周内仅服用抗精神病药物。抗精神病药物的血浆水平通过气液色谱法测定,每周早晨在两个不同时间各测定一次。方差分析显示,患者仅服用抗精神病药物时与同时服用抗精神病药物和抗帕金森病药物期间相比,抗精神病药物血浆水平存在显著差异。基于学生化极差Q0-05的多重比较显示,停用抗帕金森病药物后的12周内,抗精神病药物血浆水平显著逐渐升高,之后达到平稳状态。文中讨论了抗帕金森病药物对抗精神病药物血浆水平的假定作用机制。